Jesse Jia-Bei Zhu, a 62-year-old individual with a troubled past, left British Columbia in 2015 with legal issues stemming from his failed bull semen industry aspirations. Recently, his name resurfaced in the U.S. in connection to peculiar allegations involving biolabs in California and Nevada containing potentially hazardous substances.
Authorities discovered a suspected laboratory in a Las Vegas residence proposed by Zhu as his temporary living quarters while facing trial for distributing adulterated COVID-19 tests across the U.S. Despite being both a Chinese and Canadian citizen, Zhu’s application for release was denied, and he remains in pre-trial detention since his arrest in 2023 following the discovery of another biological lab in Fresno County, California.
The legal troubles Zhu faces today are linked to past court battles, including a significant judgment against him for stealing bull sexing technology, totaling over $270 million. Court documents reveal Zhu’s complex journey, involving questionable practices by companies tied to him and his efforts to evade legal consequences.
Zhu’s troubles escalated when authorities stumbled upon a suspicious lab in Reedley, California, linked to him, stocked with unlabeled biological substances, including hazardous pathogens. Subsequently, Zhu faced charges for unlawfully selling COVID-19 test kits in the U.S. without proper authorization from the FDA.
Recent events tied Zhu to a police raid at a Las Vegas home suspected of housing a biolab, leading to the arrest of the property manager on hazardous waste charges. Zhu’s involvement in this case remains unclear, with his lawyer stating that Zhu is focused on his upcoming trial related to the COVID kits and has been incarcerated for three years.
Meanwhile, XY LLC continues its legal pursuit against Zhu to enforce court judgments, describing his actions as a “fraud of epic proportions.” Despite Zhu’s attempts to delay legal proceedings, the company remains steadfast in seeking justice in both Canadian and Hong Kong courts.
As the legal saga continues, Zhu’s past misdeeds and questionable activities in the biolab industry have brought him under intense scrutiny, highlighting the need for greater oversight in safeguarding public health and ensuring responsible research practices.